45% of T2 diabetes patients suffer from micronutrient deficiency: Study
Bharti Jayshankar January 31, 2025: A recent meta-analysis published in BMJ Nutrition Prevention & Health reveals that more than 45% of patients with
Health
Medical
Research
Drugs
Health
Research
Cambridge researchers making brain implants to treat Parkinson’s
Researchers at Cambridge are developing implants that could help repair damaged brain cells and treat diseases like Parkinson’s.
Drugs
Health
Medical
Vertex’s non-opioid painkiller receives approval from US drug regulator
Vertex Pharmaceuticals Inc.’s non-opioid analgesic to treat moderate to severe acute pain in adults got approval from the US drug regulator.
Drugs
Health
Medical
UK’s NHS to provide gene therapy that may cure sickle cell disease in adults
Britain’s National Health Service will provide a gene therapy that may cure sickle cell disease for patients 12 years and older, according to
Medical
Research
Stem cell patches by German researchers heal damaged heart muscles
HQ Team January 30, 2025: Heart disease remains one of the leading causes of mortality worldwide, often resulting in irreversible damage to cardiac
Drugs
Health
Medical
Merck & Co stops final-stage drug trial for treating PAH
Merck & Co. halted its final-phase study of its experimental drug for pulmonary arterial hypertension after previous studies proved its “robust efficacy,” according
Drugs
Health
Medical
US ‘humanitarian wavier’ will help deliver life-saving HIV medicines: UN
The UNAIDS has welcomed a move by the United States Secretary of State, Marco Rubio, to approve an “Emergency Humanitarian Waiver” to allow
Drugs
Health
Medical
Eli Lilly halts trials of investigational chronic kidney disease drug
Eli Lilly has stopped trials of its investigational drug to treat chronic kidney disease for a “lack of foreseeable clinical benefit,” according to
Drugs
Health
Medical
Novo’ Nordisk’s drug to cut kidney disease advance in diabetics gets nod
Novo Nordisk’s medicine has been approved by the US drug regulator for reducing the risk of kidney failure and death due to cardiovascular
Health
Medical
Pharma
Zimmer Biomet to buy Paragon 28 for $1.1b to expand musculoskeletal care
Zimmer Biomet Holdings, Inc., a US medical device maker, will acquire Paragon 28 Inc., for $1.1 billion to expand into musculoskeletal care, according